Kanabo Group Plc.
("Kanabo" or the "CResult of Annual General Meeting
Kanabo Group Plc is pleased to announce that, at the Annual General Meeting ("AGM") held earlier today, all resolutions were duly passed. The numbers of votes for each resolution are presented below:
| Chairman of the meeting FOR | Chairman of the meeting AGAINST |
Total Votes Cast | ABSTAIN | |||
Resolution
| No. of shares | % | No. of shares | % | |||
1 | Receive Financial Statements | 115,542,133 | 99.75451 | 284,339 | 0.245487 | 115,826,472 | 142,706 |
2 | Approve the Directors' Remuneration Report | 115,458,280 | 99.69236 | 356,288 | 0.307637 | 115,814,568 | 154,610 |
3 | Approve the re-appointment of the auditors and authorize the directors to determine the Auditors' Remuneration | 115,553,226 | 99.75257 | 286,620 | 0.247428 | 115,839,846 | 129,332 |
4 | Re-elect Andrew Morrison | 113,469,744 | 97.99032 | 2,327,150 | 2.009683 | 115,796,894 | 172,284 |
5 | Re-elect Avihu Israel Tamir | 115,502,424 | 99.74567 | 294,510 | 0.254333 | 115,796,934 | 172,244 |
6 | Re-elect David Tsur | 115,508,799 | 99.75078 | 288,595 | 0.249224 | 115,797,394 | 171,784 |
7 | Elect Daniel Poulter | 115,509,839 | 99.75164 | 287,595 | 0.24836 | 115,797,434 | 171,744 |
8 | Elect Gil Efron | 115,509,839 | 99.75164 | 287,595 | 0.24836 | 115,797,434 | 171,744 |
9 | Authorise the directors to allot securities | 115,468,984 | 99.72081 | 323,278 | 0.279188 | 115,792,262 | 176,916 |
10* | Authorise the directors to allot Equity Securities | 115,469,484 | 99.72081 | 323,278 | 0.279187 | 115,792,762 | 176,416 |
* Special Resolution
NOTES:
Votes "For" and "Against" are expressed as a percentage of votes received.
For further information, please visit http://www.kanabogroup.com/ or https://www.voxmarkets.co.uk/listings/LON/KNB or contact the following:
Kanabo Group Plc | Via Vox Markets |
Avihu Tamir, CEO |
|
Peterhouse Capital Ltd (Financial Adviser) | Tel: +44 (0)20 7469 0930 |
Eran Zucker / Lauren Riley
Peterhouse Capital Ltd (Corporate Broker)
Lucy Williams / Charles Goodfellow Duncan Vasey / Martin Lampshire
|
|
Vox Markets (Investor Relations) | KanaboGroup@voxmarkets.co.uk |
Kat Perez | kperez@voxmarkets.co.uk |
About Kanabo Group Plc
Kanabo Group Plc is creating a new standard in the medical cannabis industry to improve the well-being of millions of people around the world by providing a better alternative to the smoking of medicinal cannabis flowers. Kanabo, which was the first medicinal cannabis company to IPO on London Stock Exchange, has a focus on the distribution of cannabis-derived products for medical patients and non-THC products for CBD consumers.
The Company has conducted extensive Research & Development to produce high-quality cannabis extract formulas, innovative medical-grade vaporizers, and various non-smoking consumption solutions. Kanabo sells a range of medical cannabis products and wellness CBD products in the Primary Markets, including its VapePod, which delivers a metered dose with every inhalation.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.